Ambrisentan Tablet, Film Coated
Product Images NDC 50090-7670

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ambrisentan (NDC 50090-7670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ambrisentan-fig1.jpg (Ambrisentan Fig1)

A scatter plot illustrating the fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of various interacting drugs relative to ambrisentan alone. The x-axis represents change relative to ambrisentan alone, and the y-axis lists interacting drugs including Cyclosporine, Mycophenolate Mofetil, Ketoconazole, Omeprazole, Rifampin, Ritonavir, Sildenafil, Tacrolimus, Tadalafil, and Warfarin.*

FDA Label Image

Ambrisentan-fig2.jpg (Ambrisentan Fig2)

A pharmacokinetic chart showing fold change and 90% confidence intervals for various interacting drugs relative to their concentration metrics (Cmax and AUC). It compares the effects of drugs like Cyclosporine, Digoxin, Ethinylestradiol, Norethindrone, Mycophenolic acid, Ritonavir, Sildenafil, Desmethylsildenafil, Tadalafil, and Warfarin and its isomers S-Warfarin and R-Warfarin, indicating changes relative to the interacting drug alone.*

FDA Label Image

Ambrisentan-fig3.jpg (Ambrisentan Fig3)

Two line graphs labeled ARIES - 1 and ARIES - 2 show changes in meters over time from baseline to week 12. Both graphs compare Placebo and different ambrisentan doses (5 mg and 10 mg in ARIES - 1; 2.5 mg and 5 mg in ARIES - 2) with lines representing each group and error bars at each time point.*

FDA Label Image

Figure 5 Time To Clinical Worsening (aries-1 And Aries-2) (Ambrisentan Fig4)

Two Kaplan-Meier survival curves labeled ARIES-1 and ARIES-2 showing event-free percentages over 12 weeks for ambrisentan versus placebo. In both graphs, solid lines represent ambrisentan and dashed lines represent placebo, showing higher event-free rates for ambrisentan. The x-axis indicates time in weeks, and the y-axis shows event-free percentage.*

FDA Label Image

Ambrisentan-str.jpg (Ambrisentan Str)

Chemical structure of ambrisentan, showing its molecular arrangement with phenyl groups, carboxylic acid, and methyl-substituted pyrimidine ring.*

FDA Label Image

Label Image (Lbl500907670)

Label of ambrisentan 10 mg film-coated tablets by A-S Medication Solutions. The label shows the product name, dosage strength, quantity of 30 tablets, storage instructions to store at 68 to 77 degrees Fahrenheit, and directions to dispense only in the original container. The label also includes NDC 50090-7670 and a QR code for dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.